247 related articles for article (PubMed ID: 30002430)
41. Improvement in antiproliferative activity of Angelica gigas Nakai by solid dispersion formation via hot-melt extrusion and induction of cell cycle arrest and apoptosis in HeLa cells.
Jiang Y; Piao J; Cho HJ; Kang WS; Kim HY
Biosci Biotechnol Biochem; 2015; 79(10):1635-43. PubMed ID: 26057458
[TBL] [Abstract][Full Text] [Related]
42. Decursin from Angelicagigas Nakai induces apoptosis in RC-58T/h/SA#4 primary human prostate cancer cells via a mitochondria-related caspase pathway.
Choi SR; Lee JH; Kim JY; Park KW; Jeong IY; Shim KH; Lee MK; Seo KI
Food Chem Toxicol; 2011 Oct; 49(10):2517-23. PubMed ID: 21693165
[TBL] [Abstract][Full Text] [Related]
43. Functional efficacy analysis of Angelica gigas Nakai on chicken myoblast cells through cell-based in vitro assay.
Lee JH; Park JW; Seo ES; Kim HU; Kim SW; Han JS; Jun HS; Kim SJ; Park TS; Park BC
Anim Sci J; 2019 Jul; 90(7):903-912. PubMed ID: 31012203
[TBL] [Abstract][Full Text] [Related]
44. Decursin prevents cisplatin-induced apoptosis via the enhancement of antioxidant enzymes in human renal epithelial cells.
Kim JH; Jeong SJ; Kwon HY; Park SY; Lee HJ; Lee HJ; Lieske JC; Kim SH
Biol Pharm Bull; 2010; 33(8):1279-84. PubMed ID: 20686219
[TBL] [Abstract][Full Text] [Related]
45. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
[TBL] [Abstract][Full Text] [Related]
46. Decursin and Z-Ligustilide in
Park Y; Kim D; Yang I; Choi B; Lee JW; Namkoong S; Koo HJ; Lee SR; Park MR; Lim H; Kim YK; Nam SJ; Sohn EH
J Microbiol Biotechnol; 2018 Jul; 28(7):1061-1067. PubMed ID: 29913552
[TBL] [Abstract][Full Text] [Related]
47. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.
Li L; Zhang J; Xing C; Kim SH; Lü J
Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885
[TBL] [Abstract][Full Text] [Related]
48. Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts.
Kim KJ; Yeon JT; Choi SW; Moon SH; Ryu BJ; Yu R; Park SJ; Kim SH; Son YJ
Bone; 2015 Dec; 81():208-216. PubMed ID: 26208796
[TBL] [Abstract][Full Text] [Related]
49. JH-4 reduces HMGB1-mediated septic responses and improves survival rate in septic mice.
Lee W; Yuseok O; Yang S; Lee BS; Lee JH; Park EK; Baek MC; Song GY; Bae JS
J Cell Biochem; 2019 Apr; 120(4):6277-6289. PubMed ID: 30378167
[TBL] [Abstract][Full Text] [Related]
50. MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
Sochalska M; Schuler F; Weiss JG; Prchal-Murphy M; Sexl V; Villunger A
Oncogene; 2017 Apr; 36(15):2066-2073. PubMed ID: 27694901
[TBL] [Abstract][Full Text] [Related]
51. FoxO3 suppresses Myc-driven lymphomagenesis.
Vandenberg CJ; Motoyama N; Cory S
Cell Death Dis; 2016 Jan; 6(1):e2046. PubMed ID: 26764572
[TBL] [Abstract][Full Text] [Related]
52. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of beta-catenin.
Song GY; Lee JH; Cho M; Park BS; Kim DE; Oh S
Mol Pharmacol; 2007 Dec; 72(6):1599-606. PubMed ID: 17855653
[TBL] [Abstract][Full Text] [Related]
53. Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi.
Lee HW; Ryu HW; Kang MG; Park D; Lee H; Shin HM; Oh SR; Kim H
Int J Biol Macromol; 2017 Apr; 97():598-605. PubMed ID: 28109809
[TBL] [Abstract][Full Text] [Related]
54. Angelica gigas Nakai extract-loaded fast-dissolving nanofiber based on poly(vinyl alcohol) and Soluplus for oral cancer therapy.
Nam S; Lee JJ; Lee SY; Jeong JY; Kang WS; Cho HJ
Int J Pharm; 2017 Jun; 526(1-2):225-234. PubMed ID: 28478278
[TBL] [Abstract][Full Text] [Related]
55. Decursin inhibits UVB-induced MMP expression in human dermal fibroblasts via regulation of nuclear factor-κB.
Hwang BM; Noh EM; Kim JS; Kim JM; Hwang JK; Kim HK; Kang JS; Kim DS; Chae HJ; You YO; Kwon KB; Lee YR
Int J Mol Med; 2013 Feb; 31(2):477-83. PubMed ID: 23232935
[TBL] [Abstract][Full Text] [Related]
56. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
[TBL] [Abstract][Full Text] [Related]
57. Rapid and Efficient Separation of Decursin and Decursinol Angelate from
Kiyonga AN; An JH; Lee KY; Lim C; Suh YG; Chin YW; Jung K
Molecules; 2019 Jun; 24(13):. PubMed ID: 31261662
[TBL] [Abstract][Full Text] [Related]
58. Decursin inhibits the growth of HeLa cervical cancer cells through PI3K/Akt signaling.
Zhu ML; Li JC; Wang L; Zhong X; Zhang YW; Tan RZ; Wang HL; Fan JM; Wang L
J Asian Nat Prod Res; 2021 Jun; 23(6):584-595. PubMed ID: 33233968
[TBL] [Abstract][Full Text] [Related]
59. Decursin prevents TPA-induced invasion through suppression of PKCα/p38/NF-κB-dependent MMP-9 expression in MCF-7 human breast carcinoma cells.
Kim JM; Noh EM; Kim MS; Hwang JK; Hwang HY; Ryu DG; Kim HJ; Yu HN; You YO; Kim JS; Youn HJ; Kwon KB; Jung SH; Lee YR
Int J Oncol; 2014 May; 44(5):1607-13. PubMed ID: 24604087
[TBL] [Abstract][Full Text] [Related]
60. Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents.
Lu J; Kim SH; Jiang C; Lee H; Guo J
Acta Pharmacol Sin; 2007 Sep; 28(9):1365-72. PubMed ID: 17723170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
